Observational studyThe journal of headache and pain2018

Sustained onabotulinumtoxinA therapeutic benefits in patients with chronic migraine over 3 years of treatment.

Michail Vikelis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.